ProShare Advisors LLC grew its position in shares of Dolby Laboratories (NYSE:DLB – Free Report) by 15.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 103,544 shares of the electronics maker’s stock after acquiring an additional 13,475 shares during the quarter. ProShare Advisors LLC owned about 0.11% of Dolby Laboratories worth $6,650,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors also recently modified their holdings of DLB. Hantz Financial Services Inc. boosted its holdings in shares of Dolby Laboratories by 166.7% during the third quarter. Hantz Financial Services Inc. now owns 352 shares of the electronics maker’s stock valued at $25,000 after acquiring an additional 220 shares during the period. Rothschild Investment LLC boosted its holdings in shares of Dolby Laboratories by 4,046.7% during the third quarter. Rothschild Investment LLC now owns 622 shares of the electronics maker’s stock valued at $45,000 after acquiring an additional 607 shares during the period. Fifth Third Bancorp boosted its holdings in shares of Dolby Laboratories by 34.7% during the fourth quarter. Fifth Third Bancorp now owns 746 shares of the electronics maker’s stock valued at $48,000 after acquiring an additional 192 shares during the period. Optiver Holding B.V. boosted its holdings in shares of Dolby Laboratories by 7,955.6% during the third quarter. Optiver Holding B.V. now owns 725 shares of the electronics maker’s stock valued at $52,000 after acquiring an additional 716 shares during the period. Finally, Aquatic Capital Management LLC acquired a new position in shares of Dolby Laboratories during the third quarter valued at $56,000. Institutional investors and hedge funds own 58.56% of the company’s stock.
Dolby Laboratories Stock Up 1.2%
Shares of NYSE DLB opened at $54.69 on Friday. Dolby Laboratories has a fifty-two week low of $52.45 and a fifty-two week high of $77.00. The firm’s 50-day simple moving average is $60.04 and its 200 day simple moving average is $63.36. The stock has a market cap of $5.17 billion, a P/E ratio of 21.62 and a beta of 0.86.
Dolby Laboratories Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Wednesday, May 20th. Shareholders of record on Tuesday, May 12th were given a $0.36 dividend. The ex-dividend date was Tuesday, May 12th. This represents a $1.44 annualized dividend and a yield of 2.6%. Dolby Laboratories’s payout ratio is 56.92%.
Insiders Place Their Bets
In other Dolby Laboratories news, CFO Robert J. Park sold 4,895 shares of the business’s stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $56.68, for a total value of $277,448.60. Following the sale, the chief financial officer directly owned 81,490 shares in the company, valued at approximately $4,618,853.20. The trade was a 5.67% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP John D. Couling sold 7,666 shares of the business’s stock in a transaction dated Tuesday, May 5th. The stock was sold at an average price of $57.55, for a total transaction of $441,178.30. Following the completion of the sale, the senior vice president owned 118,353 shares in the company, valued at approximately $6,811,215.15. This trade represents a 6.08% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 20,249 shares of company stock worth $1,157,434. 37.93% of the stock is owned by corporate insiders.
Wall Street Analyst Weigh In
DLB has been the topic of a number of recent analyst reports. Wall Street Zen cut shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a research note on Saturday, January 31st. Rosenblatt Securities restated a “buy” rating and set a $85.00 price objective on shares of Dolby Laboratories in a research note on Friday, January 30th. Weiss Ratings restated a “hold (c-)” rating on shares of Dolby Laboratories in a research note on Friday, March 27th. Finally, Barrington Research restated an “outperform” rating and set a $90.00 price objective on shares of Dolby Laboratories in a research note on Monday, April 27th. Three analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, Dolby Laboratories presently has an average rating of “Moderate Buy” and an average target price of $90.75.
View Our Latest Research Report on DLB
Dolby Laboratories Company Profile
Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.
Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.
Featured Articles
- Five stocks we like better than Dolby Laboratories
- SpaceX IPO: Opportunity? Or the Ultimate Hype Trade?
- CAVA Group’s Stock Looks Delicious After Strong Earnings
- Lowe’s Finds Support at $215 After Q1 Earnings Sell-Off
- Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook
Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLB – Free Report).
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
